OriginCell Establishes Dual Expert Workstations to Advance Oncology Immunotherapy and Automated Biobanking Solutions

Joint Unveiling Ceremony of the YuanNeng Medicine and YuanNeng Biology Expert Workstations

Li Hongming, Party Leadership Group Member and First-Level Inspector of the Shanghai Association for Science and Technology; Gu Bing, Secretary of the Party Leadership Group and Executive Vice Chairman of the Pudong New Area Association for Science and Technology; Chen Jun, Director of the Innovation Service Department of the Pudong New Area Association for Science and Technology; and Xi Donghong, Academician of the Chinese Academy of Sciences and Director of the Shanghai Pudong Activity Center, among other relevant departmental leaders, were present at the site to unveil the plaques for the two workstations.

In his welcome address, Mr. Qu Jianguo, founder of Origincell, stated that technological innovation is the core driving force of Origincell, and the establishment of the two expert workstations—Origincell Medicine and Origincell Biology—represents their respective achievements inTumorThe efforts and achievements in the fields of immunotherapy and automated biological sample storage systems have been recognized by authoritative experts in the industry. Meanwhile, a bridge has been built between enterprises and scientists, achieving deep integration of industry, academia, and research, and promoting the cell industry fromBasic Research, Clinical research moves toward true industrialization.

Mr. Qu Jianguo, Founder of Origincell

Dr. He Xiaowen, Co-founder of Origincell Medicine, presented the objectives and missions of the experts and the workstation on behalf of Origincell Medicine. He expressed his great honor in collaborating withStem CellsIn collaboration with the renowned expert team led by Professor Gao Shaorong, and with the strong support of Professor Gao’s team, Origincell is poised to significantly enhance its capabilities. Both parties have already established practical goals and action plans. Over the next three years, they will develop new technological approaches, actively tackle key challenges in tumor immunotherapy, and advance the clinical translation of related products. This effort aims to break through technical bottlenecks constraining corporate and industry development, ultimately creating tumor cell therapy products that are low-cost, highly efficacious, and possess substantial application potential. Additionally, the two parties will jointly cultivate a talent pool comprising postdoctoral fellows, PhD candidates, and master’s students.TumorA multidisciplinary team of professionals specializing in the development and translational commercialization of immunotherapy technologies and products, facilitating the rapid translation of scientific achievements into clinical applications to benefit patients and the public, thereby contributing to the grand strategy of Healthy China.

Dr. He Xiaowen, Co-founder of Origincell Medicine

Dr. Wang Jianxin, representing Origincell-Auto, outlined the objectives and tasks for the establishment of the expert workstation in collaboration with the experts: Origincell-Auto is delighted to partner with Professor Liu Baolin’s team from the University of Shanghai for Science and Technology to jointly establish an Expert Workstation. We are targeting the critical field of “cryopreservation of viable biological samples at clinical grade,” which urgently needs breakthroughs in the automated storage industry. Our research focuses on warming and cooling processes and technologies tailored to various types of viable samples, aiming to preserve their viability and functionality. This initiative seeks to propel the cryobiomedicine industry from scientific research toward industrialization, standardization, and clinical application, thereby providing strong support for the national strategic priority of “biological sample safety.”

Dr. Wang Jianxin, Executive Deputy General Manager of Origincell Bio

Following the presentation of appointment letters by Mr. Qu Jianguo and Ms. Yang Huanfeng, founders of Origincell, to the chief experts and distinguished experts of the two workstations, the appointed chief experts from each workstation delivered remarks respectively.

Appointment Certificate Issuance for the OriginCell Expert Workstation

Professor Gao Shaorong stated in his address that he has maintained a long-standing partnership with Origincell Group and has personally witnessed the group’s genuine investment and pragmatic execution under the leadership of Mr. Qu, achieving significant results in scientific research and translation. He expressed his pleasure and honor at being appointed as the Chief Expert of the Origincell Medical Expert Workstation. A collaborative research agreement has already been initiated with Origincell Medicine, accompanied by a highly specific development plan. Building on ongoing collaborative projects, the workstation will align with national and Shanghai municipal government key initiatives in this field, integrating the advantageous resources of both parties across industry, academia, research, and clinical practice. The goal is to deliver tangible outcomes and cultivate talent, striving jointly to propel Chinese cell therapy products into the international forefront.

Professor Gao Shaorong, Tongji University

Professor Liu Baolin stated in his address that automation and intelligence will become the mainstream development trend in the field of biological sample storage equipment. This shift will overcome many pain points associated with traditional sample storage models, such as ambient temperature exposure, frost accumulation and freezing, cross-contamination, manual operational errors, and difficulties in information traceability, thereby bringing about innovative transformation to the entire industry.

Origincell has established an industry-leading cryogenic biopreservation technology platform and independently developed a comprehensive product portfolio covering the entire value chain of automated cryogenic storage. With parallel advancements in front-end cryopreservation technologies and back-end automated equipment R&D, the company has achieved a world-leading position. The establishment of the Expert Workstation will facilitate the translation of mutual technological breakthroughs and innovations in "cryobiology" into every stage of Origincell’s automated equipment development, including R&D, design, manufacturing, and operation. This integration aims to achieve high efficiency, safety, controllability, automation, and intelligence, thereby sustaining industry leadership, ensuring the safety and quality of biological samples, and laying a solid foundation for the cell therapy industry.

In the collective presence of the attending guests, representatives from the government, universities, and enterprises jointly unveiled the plaques for the Origincell Biological Expert Workstation and the Origincell Medical Expert Workstation.

Unveiling Ceremony of the Origincell Medical Expert Workstation

Unveiling Ceremony of the Origincell Biological Expert Workstation

Li Hongming, representing the Shanghai Association for Science and Technology and the Pudong New Area Association for Science and Technology, delivered a speech congratulating the establishment of the two workstations. She warmly praised Origincell-Auto for its progress and achievements in the integration of industry, academia, research, medicine, and application. In her address, she stated that as we celebrate the 30th anniversary of Pudong’s development and opening-up, witnessing a single group unveil two expert workstations simultaneously—driving innovative development in two distinct fields—fully demonstrates the extraordinary vitality of Pudong as a hotbed for innovation and entrepreneurship. She expressed hope that Origincell would seize this opportunity to shoulder its social responsibilities, aim for world-class standards, scale new heights in science and technology, and cultivate more outstanding talent. With the support of the expert teams led by Professor Gao Shaorong and Professor Liu Baolin, Origincell is expected to contribute to corporate development and empower the growth of China’s biopharmaceutical industry.

Li Hongming, Member of the Party Leadership Group and First-Level Inspector of the Shanghai Association for Science and Technology

Following the unveiling ceremony, Origincell-Auto and Yuaneng Medicine each commenced offline work with the experts from the workstation.MeetingThe exploration and wisdom from university research laboratories and corporate production fronts sparked brilliant insights, bringing the unveiling ceremony to a successful conclusion.

Tips：

1. Professor Gao Shaorong

Currently serves as the Dean of the College of Life Sciences and Technology at Tongji University, and Deputy Director of the Institute for Advanced Studies in Translational Medicine. Has presided over and participated in numerous research projects funded by the National Natural Science Foundation of China, the Ministry of Science and Technology, and the Shanghai Municipal Government. Has published more than 100 papers in prestigious international academic journals such as Nature, Science, and Cell Stem Cell. Received the WuXi AppTec Life Chemistry Research Award in 2009; the Zhou Guangzhao Foundation Outstanding Young Scientist Award in Basic Sciences in 2011; and was awarded the National Science Fund for Distinguished Young Scholars in 2013. In 2014, received the Second Class Prize of the National Natural Science Award, was appointed as a “Chang Jiang Scholar” Distinguished Professor by the Ministry of Education, and was selected as a Leading Talent in Scientific and Technological Innovation among Middle-aged and Young Researchers by the Ministry of Science and Technology. In 2015, received the Tan Jiazhen Life Science Innovation Award, was selected into the National “Hundred, Thousand, and Ten Thousand Talents Project,” and was conferred the honorary title of “Middle-aged and Young Expert with Outstanding Contributions.” In 2016, was selected as a Leading Talent in the second batch of the “Ten Thousand Talents Program,” received the State Council Special Allowance, and in the same year was recognized by the China Association for Science and Technology as one of the “Top Ten Advances in Life Sciences in China.” In 2019, received the First Class Prize of the Ministry of Education Natural Science Award, and in the worldStem Cellsenjoys considerable academic prestige in the field.

2. Professor Liu Baolin

Current Dean of the School of Medical Devices and Food, University of Shanghai for Science and Technology; Deputy Director of the Engineering Research Center for Modern Minimally Invasive Medical Devices and Technology, Ministry of Education; Head of the Cryobiology Group, Tissue Biobank Branch, Chinese Society of Medicine and Biotechnology; Director of the Shanghai Cryogenic Biomedical Technology Service Platform. He received his Ph.D. in 1996 and served as a visiting scholar at Michigan State University and the University of Arizona in the United States from 2001 to 2004. He has been selected for the Ministry of Education’s New Century Excellent Talents Program, appointed as a Distinguished Professor under the Shanghai Oriental Scholar Program, and honored as a Shanghai Shuguang Scholar and Pujiang Scholar. He has published more than 200 research papers and authored three books [This section introduces the expert]. His research focuses on cryogenic biomedical engineering,Biobanklow-temperature cryopreservation technology; presided over more than 20 research projects, including those funded by the National Natural Science Foundation of China, the Fok Ying Tung Education Foundation for Young Scholars under the Ministry of Education, key breakthrough programs of the Shanghai Municipal Science and Technology Commission, key projects of the Shanghai Municipal Education Commission, and enterprise-sponsored initiatives; received four awards at the provincial/ministerial level or above.